Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -30.80 is 98% above its 5-year average of -1489.60, near the high end of its 5-year range (-8857.30–-0.68).
99.31% above its 12-month average of -4464.45.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -3.10.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 17 comparable quarters.
EARNINGS PER SHARE (EPS)
-30.80
EARNINGS PER SHARE (EPS) AVG TTM
-4464.45
EARNINGS PER SHARE (EPS) AVG 3Y
-2234.00
EARNINGS PER SHARE (EPS) AVG 5Y
-1489.60
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+99.31%
CURRENT VS 3Y AVG
+98.62%
CURRENT VS 5Y AVG
+97.93%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Shuttle Pharmaceuticals Holdings, Inc.
Market Cap
$2.44M
Earnings Per Share (EPS)
-30.80
TTM Avg
-4464.45
3Y Avg
-2234.00
5Y Avg
-1489.60
Market Cap
$2.44M
Earnings Per Share (EPS)
-5482.20
TTM Avg
-40335.15
3Y Avg
-7495867.58
5Y Avg
-46112025.05
Market Cap
$2.42M
Earnings Per Share (EPS)
-8.74
TTM Avg
-262.83
3Y Avg
-175.32
5Y Avg
-105.22
Market Cap
$2.41M
Earnings Per Share (EPS)
-6.00
TTM Avg
-7.57
3Y Avg
-7.54
5Y Avg
-5.31
Market Cap
$2.37M
Earnings Per Share (EPS)
-17.13
TTM Avg
-108.78
3Y Avg
-243.69
5Y Avg
-309.59
Market Cap
$2.53M
Earnings Per Share (EPS)
-120.15
TTM Avg
-233.70
3Y Avg
-422.85
5Y Avg
-533.30
Market Cap
$2.32M
Earnings Per Share (EPS)
-2.00
TTM Avg
-3.12
3Y Avg
-4.82
5Y Avg
-95.40
Market Cap
$2.56M
Earnings Per Share (EPS)
-132.69
TTM Avg
-152.69
3Y Avg
-28794.02
5Y Avg
-195833.20
Market Cap
$2.67M
Earnings Per Share (EPS)
-50.28
TTM Avg
-397.20
3Y Avg
-675.82
5Y Avg
-681.84
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | $2.44M | -30.80 | -4464.45 | -2234.00 | -1489.60 |
| Jaguar Health, Inc. (JAGX)vs › | $2.44M | -5482.20 | -40335.15 | -7495867.58 | -46112025.05 |
| Onconetix, Inc. (ONCO)vs › | $2.42M | -8.74 | -262.83 | -175.32 | -105.22 |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.41M | -6.00 | -7.57 | -7.54 | -5.31 |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.37M | -17.13 | -108.78 | -243.69 | -309.59 |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.53M | -120.15 | -233.70 | -422.85 | -533.30 |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | -2.00 | -3.12 | -4.82 | -95.40 |
| Nuwellis, Inc. (NUWE)vs › | $2.56M | -132.69 | -152.69 | -28794.02 | -195833.20 |
| iSpecimen Inc. (ISPC)vs › | $2.67M | -50.28 | -397.20 | -675.82 | -681.84 |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.16M | -2.06 | -2.14 | -10.33 | -14.99 |
Trailing EPS (TTM)
$-30.80
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -71.60 |
| 2024-12-31 | -8857.30 |
| 2023-12-31 | -4.10 |
| 2022-12-31 | -3.00 |
| 2021-12-31 | -0.95 |
| 2020-12-31 | -0.68 |
| 2018-12-31 | -0.46 |
| 2017-12-31 | -0.16 |
